Clinical and hormonal characteristics of central hypothyroidism at diagnosis and during follow-up in adult patients

European Journal of Endocrinology

Volumn 150, Issue 1, 2004, Pages 1-8

  Alexopoulou, O ^a   Belguin, Cl ^a   De Nayer, Ph ^a   Maiter, D ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GLUCOCORTICOID; GROWTH HORMONE; HYDROCORTISONE; HYPOPHYSIS HORMONE; LEVOTHYROXINE; LIOTHYRONINE; TESTOSTERONE; THYROTROPIN; THYROXINE;

ADOLESCENT; ADULT; AGE; ARTICLE; BIOCHEMISTRY; CENTRAL NERVOUS SYSTEM TUMOR; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; CRANIOPHARYNGIOMA; DOSE RESPONSE; EUTHYROIDISM; FATIGUE; FEMALE; FOLLOW UP; GROWTH RETARDATION; HEADACHE; HORMONE ACTION; HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; HYPOPHYSIS TUMOR; HYPOPITUITARISM; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEX DIFFERENCE; SYMPTOM; TREATMENT OUTCOME; VASCULAR DISEASE;

ADULT; AGE OF ONSET; AGED; FATIGUE; FEMALE; FOLLOW-UP STUDIES; GROWTH DISORDERS; HEADACHE; HUMAN GROWTH HORMONE; HUMANS; HYPOTHYROIDISM; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; THYROTROPIN; THYROXINE;

EID: 0742289429     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1500001     Document Type: Article

References (33)

1. Medeiros-Neto G, Herodotou DT, Rajan S, Kommareddi S, de Lacerda L, Sandrini R et al. A circulating, biologically inactive thyrotropin caused by a mutation in the beta subunit gene. Journal of Clinical Investigation 1996 97 1250-1256.
2. Collu R, Tang J, Castagne J, Lagace G, Masson N, Huot C et al. A novel mechanism for isolated central hypothyroidism: inactivating mutations in the thyrotropin-releasing hormone receptor gene. Journal of Clinical Endocrinology and Metabolism 1997 82 1561-1565.
3. Pfaffle RW, Parks JS, Brown MR & Heimann G. Pit-1 and pituitary function. Journal of Pediatric Endocrinology 1993 6 229-233.
4. Wu W, Cogan JD, Pfaffle RW, Dasen JS, Frisch H, O'Connell SM et al. Mutations in PROP1 cause familial combined pituitary hormone deficiency. Nature Genetics 1998 18 147-149.
5. Hashimoto K. The etiology of isolated thyroid stimulating hormone deficiency. Internal Medicine 1998 37 231-232.
6. Ferretti E, Persani L, Jaffrain-Rea ML, Giambona S, Tamburrano G & Beck-Peccoz P. Evaluation of the adequacy of levothyroxine replacement therapy in patients with central hypothyroidism. Journal of Clinical Endocrinology and Metabolism 1999 84 924-929.
7. Andersen S, Pedersen KM, Bruun NH & Laurberg P. Narrow individual variations in serum T4 and T3 in normal subjects: a clue to understanding of subclinical thyroid disease. Journal of Clinical Endocrinology and Metabolism 2002 87 1068-1072.
8. Tanner JM, Peter SW & Davies B. Clinical longitudinal standards for height and height velocity for North American children. Journal of Pediatrics 1985 107 317-329.
9. Price A & Weetman AP. Screening for central hypothyroidism is unjustified. British Medical Journal 2001 322 798.
10. Rose SR, Lustig RH, Pitukcheewanont P, Broome DC, Burghen GA, Li H et al. Diagnosis of hidden central hypothyroidism in survivors of child cancer. Journal of Clinical Endocrinology and Metabolism 1999 84 4472-4479.
11. Smallridge RC. Metabolic, physiological, and clinical indexes of thyroid function. In The Thyroid, edn 7, pp 397-405. Eds LE Braverman & RD Utiger. Philadelphia: Lippincott, 1996.
12. Samuels MH, Lillehei K, Kleinschmidt-Demasters BK, Stears J & Ridgway EC. Patterns of pulsatile pituitary glycoprotein secretion in central hypothyroidism and hypogonadism. Journal of Clinical Endocrinology and Metabolism 1990 70 391-395.
13. Lee KO, Persani L, Tan M, Sundram FX & Beck-Peccoz P. Thyrotropin with decreased biological activity, a delayed consequence of cranial irradiation for nasopharyngeal carcinoma. Journal of Endocrinological Investigation 1995 18 800-805.
14. Persani L, Ferretti E, Borgato S, Faglia G & Beck-Peccoz P. Circulating thyrotropin bioactivity in sporadic central hypothyroidism. Journal of Clinical Endocrinology and Metabolism 2000 85 3631-3635.
15. Faglia G, Bitensky L, Pinchera A, Ferrari C, Paracchi A, Beck-Peccoz P et al. Thyrotropin secretion in patients with central hypothyroidism: evidence for reduced biological activity of immunoreactive thyrotropin. Journal of Clinical Endocrinology and Metabolism 1979 48 989-998.
16. Rose SR. Cranial irradiation and central hypothyroidism. Trends in Endocrinology and Metabolism 2001 12 97-104.
17. Rose SR, Manasco PK, Pearce S & Nisula BC. Hypothyroidism and deficiency of the nocturnal thyrotropin surge in children with hypothalamic-pituitary disorders. Journal of Clinical Endocrinology and Metabolism 1990 70 1750-1755.
18. Helfand M & Crapo LM. Monitoring therapy in patients taking levothyroxine. Annals of Internal Medicine 1990 113 450-454.
19. Fish LH, Schwartz HL, Cavanaugh J, Steffes MW, Bantle JP & Oppenheimer JH. Replacement dose, metabolism, and bioavailability of levothyroxine in the treatment of hypothyroidism. Role of triiodothyronine in pituitary feedback in humans. New England Journal of Medicine 1987 316 764-770.
20. Griffin JE. Hypothyroidism in the elderly. American Journal of Medical Science 1990 299 334-345.
21. Carrozza V, Csako G, Yanovski JA, Skarulis MC, Nieman L, Wesley R et al. Levothyroxine replacement therapy in central hypothyroidism: a practice report. Pharmacotherapy 1999 19 349-355.
22. Bunevicius R, Kazanavicius G, Zalinkevicius R & Prange AJ Jr. Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism. New England Journal of Medicine 1999 340 424-429.
23. Gittoes NJ, Franklyn JA, Sarne DH, Refetoff S & Sheppard MC. Thyroid function tests. In Endocrinology, edn 4, pp 1361-1398. Eds LJ DeGroot & JL Jameson. Philadelphia: Saunders, 2001.
24. Ain KB, Mori Y & Refetoff S. Reduced clearance rate of thyroxine-binding globulin (TBG) with increased sialylation: a mechanism for estrogen-induced elevation of serum TBG concentration. Journal of Clinical Endocrinology and Metabolism 1987 65 689-696.
25. Robbins J, Cheng SY, Gershengorn MC, Glinoer D, Cahnmann HJ & Edelnoch H. Thyroxine transport proteins of plasma. Molecular properties and biosynthesis. Recent Progress in Hormone Research 1978 34 477-519.
26. Arafah BM. Increased need for thyroxine in women with hypothyroidism during estrogen therapy. New England Journal of Medicine 2001 344 1743-1749.
27. Portes ES, Oliveira JH, MacCagnan P & Abucham J. Changes in serum thyroid hormones levels and their mechanisms during long-term growth hormone (GH) replacement therapy in GH deficient children. Clinical Endocrinology 2000 53 183-189.
28. Jorgensen JO, Moller J, Laursen T, Orskov H, Christiansen JS & Weeke J. Growth hormone administration stimulates energy expenditure and extrathyroidal conversion of thyroxine to triiodothyronine in a dose-dependent manner and suppresses circadian thyrotrophin levels: studies in GH-deficient adults. Clinical Endocrinology 1994 41 609-614.
29. Jorgensen JO, Pedersen SA, Laurberg P, Weeke J, Skakkebaek NE & Christiansen JS. Effects of growth hormone therapy on thyroid function of growth hormone-deficient adults with and without concomitant thyroxine-substituted central hypothyroidism. Journal of Clinical Endocrinology and Metabolism 1989 69 1127-1132.
30. Grunfeld C, Sherman BM & Cavalieri RR. The acute effects of human growth hormone administration on thyroid function in normal men. Journal of Clinical Endocrinology and Metabolism 1988 67 1111-1114.
31. Porretti S, Giavoli C, Ronchi C, Lombardi G, Zaccaria M, Valle D et al. Recombinant human GH replacement therapy and thyroid function in a large group of adult GH-deficient patients: when does L-T(4) therapy become mandatory? Journal of Clinical Endocrinology and Metabolism 2002 87 2042-2045.
32. Span JP, Pieters GF, Sweep FG, Hermus AR & Smals AG. Gender differences in rhGH-induced changes in body composition in GH-deficient adults. Journal of Clinical Endocrinology and Metabolism 2001 86 4161-4165.
33. Dall R, Longobardi S, Ehrnborg C, Keay N, Rosen T, Jorgensen JO et al. The effect of four weeks of supraphysiological growth hormone administration on the insulin-like growth factor axis in women and men. GH-2000 Study Group. Journal of Clinical Endocrinology and Metabolism 2000 85 4193-4200.